Necrosis is a form a premature cell death that, unlike apoptosis, is not programmed or regulated. This form of cell death most often occurs from conditions in the environment that may result in injuries, infections, hypoxia, toxin exposure, and nutrient deprivation, as well as diseases and disorders including Alzheimer’s disease, amyotrophic lateral sclerosis, and epilepsy. The mechanism by which necrotic cell death occurs begins with receptors that cause the cell to swell until the membrane loses its integrity, which results in the cellular material being deposited into the extracellular space. This initiates an inflammatory response and the buildup of dead tissues around the site of the cell death. There are five kinds of buildup, coagulative (a buildup of gel), liquefactive (a buildup of liquid), caseous (a buildup of gel and liquid), fat (resulting from the necrosis of fat tissue), and fibrinoid (the result of vascular damage).
Necrotic Cell Death Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Necrotic Cell Death below!
For more information on how to use Laverne, please read the How to Guide.
We have 2769 products for the study of the Necrotic Cell Death Pathway that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.